Arne Hansen

Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjögren's syndrome.

Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.

Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells.

Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.

Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome.

New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.

Peracetic acid-ethanol treatment of allogeneic avital bone tissue transplants--a reliable sterilization method.

Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

Autoantibodies in normals--the value of predicting rheumatoid arthritis.

A method for the determination of the residual chloroform in defatted cancellous bone transplants.

Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy.

Cryopreserved human B cells as an alternative source for single cell mRNA analysis.

Sensitive and specific method for detecting G protein-coupled receptor mRNAs.

Using brain slice cultures of mouse brain to assess the effect of growth factors on differentiation of bone marrow derived stem cells.

Developments in lupus 2006.

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.

B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.

Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura.

Development of a drug screening platform based on engineered heart tissue.

What do we know about memory B cells in primary Sjögren's syndrome?

Myomasp/LRRC39, a heart- and muscle-specific protein, is a novel component of the sarcomeric M-band and is involved in stretch sensing.

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus.

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.

Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.

Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.

Complex interactions between human myoblasts and the surrounding 3D fibrin-based matrix.

Physiological aspects of cardiac tissue engineering.

Increased afterload induces pathological cardiac hypertrophy: a new in vitro model.

Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.

Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.

Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.

Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization.

Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.

In vitro perfusion of engineered heart tissue through endothelialized channels.

Cardiac tissue engineering: state of the art.

Automated analysis of contractile force and Ca2+ transients in engineered heart tissue.

Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.

Generation of strip-format fibrin-based engineered heart tissue (EHT).

Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue.

Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.

Immunobiology of fibrin-based engineered heart tissue.

Human engineered heart tissue as a model system for drug testing.

Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization.

Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue.

Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue.

Human Engineered Heart Tissue: Analysis of Contractile Force.

Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions.

Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.

Towards a Tissue-Engineered Contractile Fontan-Conduit: The Fate of Cardiac Myocytes in the Subpulmonary Circulation.

Thymosin β4 Improves Differentiation and Vascularization of EHTs.